A Single-blind, Randomized, Placebo-Controlled 3-Part Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled AZD0449 Following Single and Multiple Ascending Doses and to Investigate the Anti-Inflammatory Effect of Inhaled AZD0449
Latest Information Update: 26 Aug 2024
At a glance
Most Recent Events
- 26 Aug 2024 Primary endpoints has been amended.
- 29 Jun 2021 Status changed from recruiting to completed.
- 08 Apr 2021 Planned End Date changed from 31 May 2021 to 10 Jun 2021.